NM_001145648.3:c.276+4398T>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001145648.3(RASGRF1):c.276+4398T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.523 in 152,014 control chromosomes in the GnomAD database, including 23,278 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.52 ( 23278 hom., cov: 32)
Consequence
RASGRF1
NM_001145648.3 intron
NM_001145648.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.198
Publications
6 publications found
Genes affected
RASGRF1 (HGNC:9875): (Ras protein specific guanine nucleotide releasing factor 1) The protein encoded by this gene is a guanine nucleotide exchange factor (GEF) similar to the Saccharomyces cerevisiae CDC25 gene product. Functional analysis has demonstrated that this protein stimulates the dissociation of GDP from RAS protein. The studies of the similar gene in mouse suggested that the Ras-GEF activity of this protein in brain can be activated by Ca2+ influx, muscarinic receptors, and G protein beta-gamma subunit. Mouse studies also indicated that the Ras-GEF signaling pathway mediated by this protein may be important for long-term memory. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.794 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RASGRF1 | NM_001145648.3 | c.276+4398T>G | intron_variant | Intron 1 of 26 | ENST00000558480.7 | NP_001139120.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.523 AC: 79413AN: 151896Hom.: 23236 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
79413
AN:
151896
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.523 AC: 79517AN: 152014Hom.: 23278 Cov.: 32 AF XY: 0.518 AC XY: 38448AN XY: 74280 show subpopulations
GnomAD4 genome
AF:
AC:
79517
AN:
152014
Hom.:
Cov.:
32
AF XY:
AC XY:
38448
AN XY:
74280
show subpopulations
African (AFR)
AF:
AC:
33238
AN:
41478
American (AMR)
AF:
AC:
7488
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
1241
AN:
3468
East Asian (EAS)
AF:
AC:
2624
AN:
5172
South Asian (SAS)
AF:
AC:
1187
AN:
4814
European-Finnish (FIN)
AF:
AC:
4242
AN:
10536
Middle Eastern (MID)
AF:
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28166
AN:
67962
Other (OTH)
AF:
AC:
988
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1713
3426
5140
6853
8566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1184
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.